Estate Planners Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$374K Buy
6,174
+66
+1% +$3.85K 0.18% 49
2025
Q4
$329K Buy
+6,108
New +$294K 0.14% 48

Other funds holding BMY

Estate Planners Group's BMY Position: Q1 2026 in Review

Estate Planners Group increased its Bristol-Myers Squibb (BMY) stake by 1.1% in Q1 2026, buying an estimated $3.85K and bringing the position to 6,174 shares worth $374K. The position accounts for 0.18% of the portfolio, ranked #49.

Estate Planners Group first reported a position in BMY in Q4 2025 and has held it in 2 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Estate Planners Group held 6,174 shares of Bristol-Myers Squibb worth $374K as of Q1 2026.
  • Estate Planners Group bought 66 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.85K.
  • Bristol-Myers Squibb made up 0.18% of Estate Planners Group's portfolio in Q1 2026, its #49 holding.
  • Estate Planners Group first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 2 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Estate Planners Group's 13F filing for Q1 2026, filed 11 May 2026.